Closing Loopholes for Orphan Drugs Act
Latest action · Jun 16, 2017 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJun 13, 2017
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Closing Loopholes for Orphan Drugs Act
This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.Cosponsors 3
Members who signed on, in the order they did. Signatures ran from Jun 13, 2017 to Dec 12, 2018; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-MS | Gregg Harper | Original | Jun 13, 2017 |
| D-MN | Collin C. Peterson | Jun 21, 2017 | |
| D-IN | Peter J. Visclosky | Dec 12, 2018 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jun 13, 2017 |
| Health Subcommittee | Referred Jun 16, 2017 |
Actions 3
Everything that happened, newest first.
- Jun 16, 2017Referred to the Subcommittee on Health.
- Jun 13, 2017Introduced in House
- Jun 13, 2017Referred to the House Committee on Energy and Commerce.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Lists H4913H.R. 2889–2899 | — | Jun 13, 2017 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 163, no. 100, June 13, 2017, page H4913.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 115-702 | RURAL HEALTH CARE IN AMERICA: CHALLENGES AND OPPORTUNITIES169 pages | Finance Committee | May 24, 2018 |
| S. Hrg. 115-331 | INDIVIDUAL TAX REFORM146 pages | Finance Committee | Sep 14, 2017 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 4538 | Closing Loopholes for Orphan Drugs Act | Reintroduced Bill | Sep 27, 2019 |
| HR 6174 | Closing Loopholes for Orphan Drugs Act | Reintroduction of | Sep 27, 2016 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.
- Short Titles as Introduced
- Closing Loopholes for Orphan Drugs Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jun 13, 2017Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.